Key Events This Week
18 May: Stock opens at Rs.632.35, down 1.10% amid broader market weakness
19 May: Price rebounds sharply, gaining 2.27% to Rs.646.70
20 May: Strong quarterly results announced; stock closes at Rs.651.80 (+0.79%)
21 May: Profit concerns weigh; stock falls 3.80% to Rs.627.00
22 May: Recovery rally lifts stock 4.27% to Rs.653.75
Are Healthcare Global Enterprises Ltd latest results good or bad?
2026-05-21 19:28:25Healthcare Global Enterprises Ltd's latest financial results for the quarter ended March 2026 present a complex picture. The company achieved consolidated net sales of ₹652.33 crores, reflecting a year-on-year growth of 11.48%. This indicates a strong revenue performance, marking an all-time quarterly high and showcasing the company's ability to attract patients in the growing oncology market. However, this revenue growth contrasts sharply with the company's net profit, which fell to ₹2.17 crores, a significant decline of 70.52% compared to the previous year. This drastic reduction raises concerns about the company's profitability and its ability to convert revenue into net earnings. The operating margin, while improved to 19.23%, suggests better operational efficiency but does not alleviate the issues surrounding net profit. The financial data also highlights challenges related to the company's capital s...
Read full news article
Healthcare Global Q4 FY26: Profit Collapses 70% Despite Revenue Growth, Valuation Concerns Mount
2026-05-20 19:33:20Healthcare Global Enterprises Ltd., India's leading cancer care chain, reported a disappointing fourth quarter for fiscal year 2026, with consolidated net profit plummeting 70.52% year-on-year to ₹2.17 crores despite recording its highest-ever quarterly revenue. The stark contrast between topline growth and bottom-line deterioration has raised serious questions about operational efficiency and profitability sustainability at a time when the stock trades at an eye-watering valuation of 167 times trailing earnings.
Read full news article
Healthcare Global Enterprises Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Expansion
2026-05-20 11:00:26Healthcare Global Enterprises Ltd has demonstrated a remarkable financial turnaround in the quarter ended March 2026, posting its highest quarterly revenue and profit metrics in recent history. This shift from a previously negative trend to a very positive performance signals renewed investor confidence and operational strength within the hospital sector.
Read full news article
Healthcare Global Enterprises Ltd is Rated Hold by MarketsMOJO
2026-05-20 10:10:03Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating was revised on this date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read full news article
Healthcare Global Enterprises Ltd Surges 7.23% to Day's High of Rs 661.4 — Outperforms Sector by 6.5 Percentage Points
2026-05-15 11:01:08The Sensex rose 0.53% on 15 May 2026, yet Healthcare Global Enterprises Ltd outpaced the broader market with a 7.23% gain, touching an intraday high of Rs 661.4. This 6.5-percentage-point outperformance over its Hospital sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Healthcare Global Enterprises Ltd is Rated Sell
2026-05-09 10:10:36Healthcare Global Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Healthcare Global Enterprises Ltd is Rated Sell
2026-04-28 10:10:55Healthcare Global Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with the most recent insights into its performance and outlook.
Read full news article





